行情

ELGX

ELGX

恩多勒吉克斯
NASDAQ

实时行情|Nasdaq Last Sale

4.050
+0.160
+4.11%
盘后: 4.050 0 0.00% 16:40 09/20 EDT
开盘
3.920
昨收
3.890
最高
4.100
最低
3.840
成交量
35.91万
成交额
--
52周最高
22.00
52周最低
3.840
市值
7,133.13万
市盈率(TTM)
-0.5436
分时
5日
1月
3月
1年
5年

分析师评级

10位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ELGX 新闻

  • The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering
  • Benzinga.1天前
  • 46 Biggest Movers From Yesterday
  • Benzinga.1天前
  • The Daily Biotech Pulse: China Biologics Receives Buyout Offer, Provention Bio Offering, Exagen IPO
  • Benzinga.2天前
  • Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • Business Wire.5天前

更多

所属板块

医疗设备、用品及经销
+0.15%
医疗设备和用品
-0.22%

热门股票

名称
价格
涨跌幅

ELGX 简况

Endologix, Inc. is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company's products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms, including traditional minimally invasive endovascular repair (EVAR) or endovascular sealing (EVAS), its solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The EVAR products include the Endologix AFX Endovascular AAA System (AFX), the VELA Proximal Endograft (VELA) and the Endologix Powerlink with Intuitrak Delivery System (Intuitrak). The EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). It offers accessories to facilitate the optimal delivery of its EVAR products, including compatible guidewires, snares, and catheter introducer sheaths.
展开

Webull提供Endologix, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。